|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PHVS
|
Pharvaris N.V.
|
US
|
NASDAQ
|
|
PLX
|
Protalix BioTherapeutics, Inc.
|
US
|
AMEX
|
|
PLXP
|
PLx Pharma Inc.
|
US
|
NASDAQ
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
US
|
NASDAQ
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
US
|
NASDAQ
|
|
PRQR
|
ProQR Therapeutics B.V.
|
US
|
NASDAQ
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
PRTK
|
Paratek Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
US
|
NASDAQ
|
|
PSNL
|
Personalis, Inc.
|
US
|
NASDAQ
|
|
PSTX
|
Poseida Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PTN
|
Palatin Technologies, Inc.
|
US
|
AMEX
|
|
QURE
|
uniQure N.V.
|
US
|
NASDAQ
|
|
RANI
|
Rani Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
US
|
NYSE
|